Numira Biosciences
Imaging services for disease research, drug discovery, and.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
N/A | Seed | ||
| Total Funding | 000k | ||
Related Content
Numira Bio is a biopharmaceutical company focused on developing innovative solutions to address unmet medical needs. Operating in the healthcare and biotechnology market, Numira Bio serves a diverse range of clients including hospitals, research institutions, and pharmaceutical companies. The company's business model revolves around the research, development, and commercialization of novel therapeutics and diagnostic tools. Revenue is generated through the sale of proprietary drugs, licensing agreements, and partnerships with other healthcare entities. Numira Bio leverages advanced technology and a robust R&D pipeline to create high-impact medical solutions, aiming to improve patient outcomes and advance the field of medicine.
Keywords: biopharmaceutical, healthcare, biotechnology, therapeutics, diagnostics, R&D, hospitals, research institutions, pharmaceutical companies, medical solutions.